<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <funding-statement>Centers for Disease Control and Prevention (CDC), and Pennsylvania Department of Health co-authors do not have any financial interests or relationships to disclose. Henry Ford Health System receives funding for CHeCS from the CDC and from Gilead Sciences. CHeCS was previously funded through May 2016 by the CDC Foundation, which received grants from AbbVie; Genentech, A Member of the Roche Group; Gilead Sciences; Janssen Pharmaceuticals, Inc. and Vertex Pharmaceuticals; past partial funders include Bristol- Myers Squibb. Granting corporations do not have access to CHeCS data and do not contribute to data analysis or writing of manuscripts. This research was also funded by the CDC Epidemiology Elective Program for its support of co-author Perry Dubin.</funding-statement>
</funding-group>
